A Korean Post-Marketing Surveillance Study On Pergoveris® (Follitropin Alfa + Lutropin Alfa)
Phase of Trial: Phase IV
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Follitropin alfa/lutropin alfa (Primary)
- Indications Female infertility
- Focus Adverse reactions
- Sponsors Merck KGaA
- 01 Jul 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Feb 2012 Actual initiation date changed from Jul 2011 to Aug 2011 as reported by ClinicalTrials.gov.
- 14 Feb 2012 Planned End Date changed from 1 Feb 2014 to 1 Aug 2014 as reported by ClinicalTrials.gov.